OncoCyte (OCX) Balance Sheet Annual - Discounting Cash Flows
OncoCyte Corporation
OCX (AMEX)

* (except for per share items) of USD
Period Ending: 2023
12-31
2022
12-31
2021
12-31
2020
12-31
2019
12-31
2018
12-31
2017
12-31
2016
12-31
2015
12-31
2014
12-31
2013
12-31
Report Filing: 2024-04-16 2023-04-12 2022-03-11 2021-03-19 2020-04-28 2019-04-01 2018-04-02 2017-02-27 2016-05-24 2014-12-31 2013-12-31
Total Current Assets 10.7 25.5 39.1 9.23 23.0 8.64 8.53 12.7 10.9 3.65 4.85
Cash and Short Term Investments 9.43 20.4 36.5 7.82 22.5 8.46 8.36 12.4 10.5 3.54 4.73
Cash & Equivalents 9.43 20.0 35.6 7.14 22.1 8.03 7.60 10.2 8.00 0.26 0.10
Short Term Investments 0.00 0.43 0.90 0.68 0.38 0.43 0.76 2.24 2.54 3.28 4.63
Receivables 0.48 2.01 1.44 0.20 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Inventory 0.00 2.12 0.30 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Current Assets 0.78 0.98 0.89 1.20 0.50 0.18 0.17 0.28 0.39 0.11 0.12
Total Assets 74.9 100 160 55.4 39.9 9.52 10.2 14.4 12.7 6.36 8.29
Total Non-Current Assets 64.2 74.6 120 46.2 16.9 0.88 1.69 1.75 1.81 2.70 3.44
Property, Plant and Equipment 5.44 10.9 8.53 6.52 3.73 0.61 0.82 0.69 0.58 0.12 0.15
Goodwill and Intangible Assets 56.6 61.6 110 24.2 0.00 0.00 0.75 0.99 1.23 1.47 1.71
Goodwill 0.00 0.00 18.7 9.19 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Intangible Assets 56.6 61.6 91.2 15.0 0.00 0.00 0.75 0.99 1.23 1.47 1.71
Long Term Investments 1.70 1.70 1.70 13.4 11.0 0.00 0.00 0.00 0.00 0.00 -1.57
Deferred Tax Assets 0.00 -1.70 -1.70 0.12 0.00 0.00 0.00 0.00 0.00 1.12 1.57
Other Long Term Assets 0.46 2.07 1.96 1.94 2.21 0.26 0.12 0.08 0.00 0.00 1.57
Total Current Liabilities 7.19 12.1 14.1 9.00 4.44 5.56 4.45 4.28 2.31 7.43 4.67
Accounts Payable 0.95 1.25 2.45 0.43 0.47 0.17 0.18 0.42 0.28 0.14 0.10
Notes Payable/Short Term Debt 0.66 0.82 2.13 2.81 1.36 1.18 1.14 0.20 0.85 5.89 2.96
Tax Payables 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Revenue 0.00 0.00 0.00 5.15 0.00 0.00 0.00 0.00 -0.85 0.00 0.00
Other Current Liabilities 5.58 10.0 9.54 0.60 2.62 4.21 3.14 3.65 2.03 1.40 1.61
Total Liabilities 49.3 65.8 94.3 21.9 9.02 6.10 5.81 4.58 2.31 7.43 4.67
Total Non-Current Liabilities 42.1 53.7 80.2 12.9 4.58 0.53 1.36 0.31 0.00 0.00 0.00
Total Long Term Debt 2.20 2.73 3.54 5.82 4.58 0.53 1.36 0.31 0.00 0.00 0.00
Deferred Tax Liabilities Non-Current 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Revenue Non-Current 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Capital Lease Obligations 2.87 3.54 4.36 4.73 2.91 0.57 0.63 0.51 0.00 0.00 0.00
Other Long Term Liabilities 37.0 47.4 72.3 2.39 -2.91 -0.57 -0.63 -0.51 0.00 0.00 0.00
Total Equity 25.6 34.3 65.2 33.5 30.8 3.42 4.40 9.86 10.4 -1.07 3.62
Non-Controlling Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Stockholders' Equity 25.6 34.3 65.2 33.5 30.8 3.42 4.40 9.86 10.4 -1.07 3.62
Retained Earnings -290 -261 -188 -124 -93.7 -71.3 -54.7 -35.3 -24.1 -15.4 -10.4
Accumulated Other Earnings 0.05 0.04 0.04 0.00 0.00 0.00 -0.89 -0.65 -0.35 -0.82 -1.37
Common Stock 310 295 253 157 125 74.7 60.0 45.8 34.9 15.1 15.4
Preferred Stock 5.13 5.30 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Additional Paid in Capital 0.00 -5.30 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Liabilities & Total Equity 74.9 100 160 55.4 39.9 9.52 10.2 14.4 12.7 6.36 8.29
Total Liabilities & Shareholders' Equity 74.9 100 160 55.4 39.9 9.52 10.2 14.4 12.7 6.36 8.29
Total Investments 1.70 0.43 0.90 14.1 11.3 0.43 0.76 2.24 2.54 3.28 4.63
Total Debt 2.87 3.54 5.68 8.63 5.94 1.72 2.50 0.51 0.85 5.89 2.96
Net Debt -6.56 -16.4 -29.9 1.49 -16.1 -6.32 -5.10 -9.66 -7.15 5.63 2.86
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us